Adagio Medical Inc.

NASDAQ: ADGM · Real-Time Price · USD
1.27
0.01 (0.40%)
At close: Aug 15, 2025, 9:30 AM

Adagio Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.28M -38.15M 1.07M -19.94M
Depreciation & Amortization
646K 532K 495K 336K
Stock-Based Compensation
642K 442K 365K 339K
Other Working Capital
9.69M 5.77M n/a n/a
Other Non-Cash Items
4M 8.73M -2.08M -623K
Deferred Income Tax
-1.92M n/a n/a n/a
Change in Working Capital
5.79M 2.79M 523.88K 579K
Operating Cash Flow
-15.99M -25.65M -485.19K -19.31M
Capital Expenditures
-368K -340K -502K -1.27M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a -149.5M
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a -7K n/a -14K
Investing Cash Flow
-368K -340K -500K -1.27M
Debt Repayment
15.63M 21.86M 120K -34.14K
Common Stock Repurchased
n/a -115.07M n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
15.63M 18K 9.45M 130K
Financial Cash Flow
15.63M 21.88M 75K 151.07M
Net Cash Flow
-701K -4.16M -410.19K -20.38M
Free Cash Flow
-16.36M -25.99M -987.19K -2.34M